ScripsAmerica Inc
ScripsAmerica, Inc. develops and sells non-sterile topical and transdermal pain creams. The company also provides pharmacy dispensing services for individual doctors, as well as billing and administrative services to independent pharmacies. In addition, it distributes pharmaceutical products to independent pharmacies and other medical providers. The company was founded in 2008 and is based in Cli… Read more
Market Cap & Net Worth: ScripsAmerica Inc (SCRCQ)
ScripsAmerica Inc (PINK:SCRCQ) has a market capitalization of $14.11K ($14.11K) as of March 19, 2026. Listed on the PINK stock exchange, this USA-based company holds position #44595 globally and #14111 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying ScripsAmerica Inc's stock price $0.00 by its total outstanding shares 141084564 (141.08 Million).
ScripsAmerica Inc Market Cap History: 2015 to 2025
ScripsAmerica Inc's market capitalization history from 2015 to 2025. Data shows change from $4.23 Million to $14.11K (-44.20% CAGR).
ScripsAmerica Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how ScripsAmerica Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of SCRCQ by Market Capitalization
Companies near ScripsAmerica Inc in the global market cap rankings as of March 19, 2026.
Key companies related to ScripsAmerica Inc by market ranking:
- Alibaba Health Information Technology Limited (PINK:ALBBY): Ranked #1435 globally with a market cap of $12.50 Billion USD.
- Walgreens Boots Alliance Inc (NASDAQ:WBA): Ranked #1880 globally with a market cap of $8.58 Billion USD.
- Raia Drogasil S.A (SA:RADL3): Ranked #2749 globally with a market cap of $5.08 Billion USD ( R$30.91 Billion BRL).
- Clicks Group Ltd (PINK:CLCGY): Ranked #2859 globally with a market cap of $4.80 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #1435 | Alibaba Health Information Technology Limited | PINK:ALBBY | $12.50 Billion | $12.32 |
| #1880 | Walgreens Boots Alliance Inc | NASDAQ:WBA | $8.58 Billion | $11.98 |
| #2749 | Raia Drogasil S.A | SA:RADL3 | $5.08 Billion | R$23.58 |
| #2859 | Clicks Group Ltd | PINK:CLCGY | $4.80 Billion | $35.11 |
ScripsAmerica Inc Historical Marketcap From 2015 to 2025
Between 2015 and today, ScripsAmerica Inc's market cap moved from $4.23 Million to $ 14.11K, with a yearly change of -44.20%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $14.11K | 0.00% |
| 2024 | $14.11K | 0.00% |
| 2023 | $14.11K | 0.00% |
| 2022 | $14.11K | -75.00% |
| 2021 | $56.43K | -50.00% |
| 2020 | $112.87K | +14.29% |
| 2019 | $98.76K | +16.67% |
| 2018 | $84.65K | -14.29% |
| 2017 | $98.76K | +16.67% |
| 2016 | $84.65K | -98.00% |
| 2015 | $4.23 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of ScripsAmerica Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $14.11K USD |
| MoneyControl | $14.11K USD |
| MarketWatch | $14.11K USD |
| marketcap.company | $14.11K USD |
| Reuters | $14.11K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.